NFKB1 and aneurysmal bone cyst: Since MYD88 L265P mutation is a hallmark of lymphoma with lymphoplasmacytic features and activated NF-κB signaling pathway, the higher frequency of MYD88 mutations in the ABC phenotype suggests that this subtype may derive from cells with those features.